Pharmaceutical potential of phorbol esters from Jatropha curcas oil

Natural Product Research

Volumn 27, Issue 16, 2013, Pages 1459-1462

  Devappa, Rakshit K ^a   Malakar, Chandi C ^a   Makkar, Harinder P S ^a   Becker, Klaus ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

By product; Jatropha; Phorbol esters; Prostratin; Toxicity

Indexed keywords

BIODIESEL; DITERPENE; ESSENTIAL OIL; JATROPHA CURCAS EXTRACT; PHORBOL ESTER DERIVATIVE; PROSTRATIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; JATROPHA CURCAS; LIQUID CHROMATOGRAPHY; NONHUMAN; PLANT SEED;

JATROPHA; PHORBOL ESTERS; PLANT OILS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84884224173     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2012.716057     Document Type: Article

References (18)

1. Cairnes, D.A., Mirvish, S.S., Wallcave, L., Nagel, D.L., & Smith, J.W. (1981). A rapid method for isolating phorbol from croton oil. Cancer Letters, 14, 85-91.
2. Cox, P.A. (2001). Ensuring equitable benefits: the Falealupo Convenant and the isolation of anti-viral drug prostratin from a Samoan medicinal plant. Pharmaceutical Biology, 39, 33-40.
3. GEXSI 2008). Global Market Study on Jatropha, Final Report; Prepared for the World Wide Fund for Nature (WWF), London/Berlin. Retrieved from http://www.jatropha-alliance.org/fileadmin/documents/GEXSI-Global-Jatropha- Study-FULL-REPORT.pdf
4. Goel, G., Makkar, H.P., Francis, G., & Becker, K. (2007). Phorbol esters: structure, biological activity, and toxicity in animals. International Journal of Toxicology, 26, 279-288.
5. Gustafson, K.R., Cardellina 2nd, J.H., McMahon, J.B., Gulakowski, R.J., Ishitoya, J., Szallasi, Z., Boyd, M.R. (1992). A nonpromoting phorbol from the Samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. Journal of Medicinal Chemistry, 35, 1978-1986.
6. Haas, W., Sterk, H., & Mittlebach, M. (2002). Novel 12-deoxy-16-hydroxyphorbol diesters isolated from the seed oil of Jatropha curcas. Journal of Natural Products, 65, 1434-1440.
7. Hirota, M., Suttajit, M., Suguri, H., Endo, Y., Shudo, K., Wongchai, V., Fujiki, H. (1988). A new tumour promoter from the seed oil of Jatropha curcas L., an intramolecular diester of 12-deoxy-16- hydroxyphorbol. Cancer Research, 48, 5800-5804.
8. Johnson, H.E., Banack, S.A., & Cox, P.A. (2008). Variability in content of the anti-AIDS drug candidate prostratin in Samoan populations of Homalanthus nutans. Journal of Natural Products, 71, 2041-2044.
9. Kulkosky, J., Culnan, D.M., Roman, J., Dornadula, G., Schnell, M., Boyd, M.R., & Pomerantz, R.J. (2001). Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood, 98, 3006-3015.
10. Makkar, H.P.S., & Becker, K. (2009). Jatropha curcas, a promising crop for the generation of biodiesel and value-added coproducts. European Journal of lipid Science and Technology, 111, 773-787.
11. Makkar, H.P.S., Becker, K., Sporer, F., & Wink, M. (1997). Studies on nutritive potential and toxic constituents of different provenances of Jatropha curcas. Journal of Agricultural Food Chemistry, 45, 3152-3157.
12. Miana, G.A., Bashir, M., & Evans, F.J. (1985). Isolation of Prostratin from Euphorbia cornigera. Planta Medica, 51, 353-354.
13. Szallasi, Z., & Blumberg, P.M. (1991). Prostratin, a nonpromoting phorbol ester, inhibits induction by phorbol 12-myristate 13-acetate of ornithine decarboxylase, edema, and hyperplasia in CD-1 mouse skin. Cancer Research, 51, 5355-5360.
14. Szallasi, Z., Krausz, K.W., & Blumberg, P.M. (1992). Non-promoting 12-deoxyphorbol 13-esters as potent inhibitors of phorbol 12-myristate 13-acetate-induced acute and chronic biological responses in CD-1 mouse skin. Carcinogenesis, 13, 2161-2167.
15. Szallasi, Z., Krsmanovic, L., & Blumberg, P.M. (1993). Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumour promotion in CD-1 mouse skin. Cancer Research, 53, 2507-2512.
16. Ventura, C., & Maioli, M. (2001). Protein kinase C control of gene expression. Critical Review in Eukaryotic Gene Expression, 11, 243-267.
17. Wender, P.A., Kee, J.M., & Warrington, J.M. (2008). Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV. Science, 320, 649-652.
18. Wender, P.A., Warrington, & J., Kee, J. (2009). Process to produce prostratin and structural or functional analogs thereof. United States patent publication number - U.S. 2009/0187046.